Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB05325> ?p ?o ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05325 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05325 label "INGN 225 [drugbank:DB05325]" assertion.
- drugbank:DB05325 seeAlso DB05325 assertion.
- drugbank:DB05325 description "INGN 225 is a therapeutic consisting of a cancer patient's own immune cells treated with an adenovector carrying the human p53 gene, Ad-p53. INGN 225 is currently in Phase 1/2 trials in patients with small cell lung cancer and breast cancer." assertion.
- drugbank:DB05325 identifier "drugbank:DB05325" assertion.
- drugbank:DB05325 title "INGN 225" assertion.
- drugbank:DB05325 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05325 drugbank_vocabulary:drugbank-id "DB05325" assertion.
- drugbank:DB05325 bio2rdf_vocabulary:x-identifiers.org DB05325 assertion.
- drugbank:DB05325 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05325" assertion.
- drugbank:DB05325 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05325 bio2rdf_vocabulary:identifier "DB05325" assertion.